Search research articles
Contact Us
Filters
Showing results (141-150 of 225) with videos related to
Page
of 23
Sort By:
JAMA
|
November 2, 2021
Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial
Julia A Bielicki, Wolfgang Stöhr, Sam Barratt, et al.
The Journal of Infection
|
January 18, 2025
Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study
Shuo Feng, Sagida Bibi, Parvinder K Aley, et al.
Clinical and Translational Science
|
October 20, 2021
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial
Susanne H Hodgson, Poppy Iveson, Jessica Larwood, et al.
Vaccine
|
December 31, 2025
Enablers and barriers to participation in vaccine trials: a narrative synthesis
Nadia Daniel, Christine Smith, Nasima Miah, et al.
The Lancet. Infectious Diseases
|
January 12, 2015
Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial
Mildred A Iro, Ameneh Khatami, Andrew S J Marshall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 24, 2012
Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans
Patrick J Lillie, Tamara K Berthoud, Timothy J Powell, et al.
ACS Infectious Diseases
|
April 25, 2020
Discovery of Cephalosporin-3'-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against <i>Pseudomonas aeruginosa</i> Clinical Cystic Fibrosis Isolates and Efficacy in a Murine Respiratory Infection Model
Ardeshir Rineh, Odel Soren, Timothy McEwan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 24, 2012
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study
Woolf T Walker, Philip de Whalley, Nick Andrews, et al.
The Pediatric Infectious Disease Journal
|
December 15, 2010
Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial
Matthew D Snape, Chaam L Klinger, Elvis D Daniels, et al.
Scientific Reports
|
February 23, 2018
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
Carly M Bliss, Georgina Bowyer, Nicholas A Anagnostou, et al.
Page
of 23
Search research articles
Search
Showing results (141-150 of 225) with videos related to
Sort By:
Page
of 23
JAMA
|
November 2, 2021
Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial
Julia A Bielicki, Wolfgang Stöhr, Sam Barratt, et al.
The Journal of Infection
|
January 18, 2025
Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study
Shuo Feng, Sagida Bibi, Parvinder K Aley, et al.
Clinical and Translational Science
|
October 20, 2021
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial
Susanne H Hodgson, Poppy Iveson, Jessica Larwood, et al.
Vaccine
|
December 31, 2025
Enablers and barriers to participation in vaccine trials: a narrative synthesis
Nadia Daniel, Christine Smith, Nasima Miah, et al.
The Lancet. Infectious Diseases
|
January 12, 2015
Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial
Mildred A Iro, Ameneh Khatami, Andrew S J Marshall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 24, 2012
Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans
Patrick J Lillie, Tamara K Berthoud, Timothy J Powell, et al.
ACS Infectious Diseases
|
April 25, 2020
Discovery of Cephalosporin-3'-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against <i>Pseudomonas aeruginosa</i> Clinical Cystic Fibrosis Isolates and Efficacy in a Murine Respiratory Infection Model
Ardeshir Rineh, Odel Soren, Timothy McEwan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 24, 2012
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study
Woolf T Walker, Philip de Whalley, Nick Andrews, et al.
The Pediatric Infectious Disease Journal
|
December 15, 2010
Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial
Matthew D Snape, Chaam L Klinger, Elvis D Daniels, et al.
Scientific Reports
|
February 23, 2018
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
Carly M Bliss, Georgina Bowyer, Nicholas A Anagnostou, et al.
Page
of 23